{3-(3-Bromo-phenyl)-2-[(furan-2-carbonyl)-amino]-acryloylamino}-acetic acid

ID: ALA366034

Chembl Id: CHEMBL366034

PubChem CID: 2270052

Max Phase: Preclinical

Molecular Formula: C16H13BrN2O5

Molecular Weight: 393.19

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)CNC(=O)/C(=C\c1cccc(Br)c1)NC(=O)c1ccco1

Standard InChI:  InChI=1S/C16H13BrN2O5/c17-11-4-1-3-10(7-11)8-12(15(22)18-9-14(20)21)19-16(23)13-5-2-6-24-13/h1-8H,9H2,(H,18,22)(H,19,23)(H,20,21)/b12-8+

Standard InChI Key:  BYXZFAIHAQVBAH-XYOKQWHBSA-N

Associated Targets(Human)

ADAM12 Tchem ADAM12 (7 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADAM9 Tchem ADAM9 (81 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADAM10 Tchem ADAM10 (375 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADAM17 Tchem ADAM17 (3550 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 393.19Molecular Weight (Monoisotopic): 392.0008AlogP: 2.01#Rotatable Bonds: 6
Polar Surface Area: 108.64Molecular Species: ACIDHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.24CX Basic pKa: CX LogP: 1.38CX LogD: -2.06
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.65Np Likeness Score: -1.33

References

1. Oh M, Im I, Lee YJ, Kim YH, Yoon JH, Park HG, Higashiyama S, Kim YC, Park WJ..  (2004)  Structure-based virtual screening and biological evaluation of potent and selective ADAM12 inhibitors.,  14  (24): [PMID:15546732] [10.1016/j.bmcl.2004.09.082]

Source